• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

The Role of Immune Cells and Traditional Chinese Medicine in Acute-on-Chronic Liver Failure

Corresponding author: wangxiufeng, 52912236@qq.com
DOI: 10.12201/bmr.202504.00030
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Acute-on-chronic liver failure (ACLF) is an acute liver injury superimposed on a chronic liver disease, with jaundice and coagulation dysfunction as the main clinical manifestations. Some patients also suffer from multi-organ failure, leading to a high mortality rate. The pathogenesis of ACLF involves the activation of immune cells and inflammatory responses. Immune cells play a key role in ACLF, including monocytes, macrophages, T lymphocytes, dendritic cells, etc. These cells secrete cytokines, participating in the repair and injury of hepatocytes. Traditional Chinese medicine (TCM) has the characteristics of multiple pathways and multiple targets. It can regulate the relevant factors of the immune system to improve the imbalance of inflammatory responses in ACLF, thereby achieving the goal of preventing and treating ACLF. Therefore, this article starts from the relationship between immune cells and ACLF, elaborates on the role of immune cells in ACLF, and how TCM intervention regulates the functions of immune cells and the expression of cytokines, providing a new perspective for the treatment of ACLF.

    Key words: acute-on-chronic liver failure; immunocyte; traditional chinese medicine

    Submit time: 11 April 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • XIE Wei, WANG Ruoyu, PENG Jianping, ZHAN Tao, CHEN Bin, WU Yunan. Prognostic predictive value of indocyanine green 15-minute retention rate combined with plasma ammonia and end-stage liver disease model score in patients with HBV-associated slow plus acute liver failure. 2025. doi: 10.12201/bmr.202507.00064

    任前军, Lisu, Chenyuqing, luweiqing, mengxiaozu, Zhaoxiaofang, Liuxudong. Research Progress of Granulocyte Colony Stimulating Factor in the Treatment of Liver Failure. 2025. doi: 10.12201/bmr.202505.00003

    Wang Hebao. Exploring the Pathogenesis of Chronic Hepatitis B from the Perspective of Traditional Chinese Medicine. 2025. doi: 10.12201/bmr.202508.00016

    胡铁骊. Research on the Construction of Catalogue System in Traditional Chinese Medicine Data Resources. 2023. doi: 10.12201/bmr.202312.00025

    Xu Jingwen, Zhu Yan. Research status of ontology in the field of traditional Chinese Medicine. 2022. doi: 10.12201/bmr.202207.00006

    zhu xinye, qian aibing. Spatial Characteristics and Dynamic Evolution of Human Resources in Traditional Chinese Medicine in china. 2023. doi: 10.12201/bmr.202312.00009

    zhoutai, zhegnqing. Discussion on the continuity of traditional Chinese medicine culture from the perspective of. 2024. doi: 10.12201/bmr.202412.00013

    GONG Xianhe, HE Minmei▲. Analysis of Payment Policies for Traditional Chinese Medicine Services. 2025. doi: 10.12201/bmr.202501.00077

    Zhu Yan, Xu Jingwen. Thinking and Prospect of ontology research of traditional Chinese Medicine——From term set to ontology set. 2022. doi: 10.12201/bmr.202206.00002

    zhangyiran, LiQiang, 肖勇, 车玉霞, 朱佳卿. Development Course and Prospect of Information Standards of Traditional Chinese Medicine in China. 2021. doi: 10.12201/bmr.202107.00008

  • ID Submit time Number Download
    1 2025-03-20

    10.12201/bmr.202504.00030V1

    Download
  • Public  Anonymous  To author only

Get Citation

wangminggang, luojuan, mozhengyuan, chenxinxin, wangxiufeng. The Role of Immune Cells and Traditional Chinese Medicine in Acute-on-Chronic Liver Failure. 2025. biomedRxiv.202504.00030

Article Metrics

  • Read: 725
  • Download: 2
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误